Biovest International, Inc. (BVTI) Company Profile - CorporateInformation.com

Company Search:

Advanced Search

Wright Investors Service Perspectives


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Biovest International, Inc. Company Snapshot

Business Description:

Biovest International, Inc. operates in the Pharmaceutical preparations sector. Biovest International, Inc. (Biovest) operates through three primary business segments: development of BiovaxID and other B-cell blood cancer vaccines; the manufacture and sale of AutovaxID and other instruments and consumables, and commercial production of cell culture products and services. The Company through its collaboration with the National Cancer Institute (NCI), is developing BiovaxID as a personalized therapeutic cancer vaccine for the treatment of non-Hodgkin's lymphoma, specifically follicular lymphoma (FL), mantle cell lymphoma (MCL) and other B-cell blood cancers. Three clinical trials conducted under the Company's Investigational New Drug Application (IND) have studied BiovaxID in non-Hodgkin's lymphoma. These studies include a Phase II clinical trial and a Phase III clinical trial in patients with FL, as well as, a Phase II clinical trial in MCL patients. As of September 30, 2010, Biovest is a 75% owned subsidiary of Accentia Biopharmaceuticals, Inc. (Accentia). In our complete report available for purchase the company is compared to: Profire Energy, Incorporation, Zap and Scientific Industries, Inc..

Biovest International, Inc.

Stock Performance Chart for Biovest International, Inc.

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): .76
(Figures in U.S. Dollars)

1 Week	2.7%		13 Weeks	100.0%

4 Weeks	100.0%		52 Weeks	7.0%

Biovest International, Inc. Key Data:

	Ticker:	BVTI	Country:	UNITED STATES

	Exchanges:	OTC	Major Industry:	Miscellaneous

			Sub Industry:	Scientific Equipment & Supplies

	2011 Sales	3,881,000 (Year Ending Jan 2012).	Employees:	36

	Currency:	U.S. Dollars	Market Cap:	109,720,595

	Fiscal Yr Ends:	September	Shares Outstanding:	144,369,204

	Share Type:		Closely Held Shares:	15,093,476

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.